Conditions Measured | Shivashankar20,21, 2012, 2013 | Al-Jarallah9, 2013 | Zippi14, 2014 | Kamo15, 2015** | Isene16, 2015 | Subramaniam17, 2015** | Peluso22, 2016 |
---|---|---|---|---|---|---|---|
Overall IBD-SpA, n | 72 | 45 | 240 | 46 | 99 | 140 | 78 |
Dactylitis | NA | 2 (4.4) | NA | 7 (15.2) | NA | 6 (4.3) | 12 (15.4) |
Enthesitis | 49 (68) | 7 (15.5) | NA | 15 (32.6) | NA | 24 (17.1) | NA |
Uveitis | 24 (33.3) | NA | 26 (10.8) | 1 (2.1) | 10 (10.1) | 8 (5.7) | NA |
B27 | NA | NA | NA | NA | NA | NA | NA |
Psoriasis | 23 (31.9) | NA | NA | NA | NA | 8 (5.7) | NA |
UC-SpA, n | 40 | 27 | 169 | NA | 51 | 44 | 34 |
Dactylitis, n | NA | 2 (7.4) | NA | NA | NA | 3 (6.8) | 2 (5.9) |
Enthesitis | 29 (72.5) | 6 (22.2) | NA | NA | NA | 6 (13.6) | NA |
Uveitis | 12 (30) | NA | 10 (5.9) | NA | 5 (9.8) | 1 (2.3) | NA |
CD-SpA, n | 32 | 18 | 71 | NA | 48 | 96 | 44 |
Dactylitis | NA | 0 (0) | NA | NA | NA | 3 (3.1) | 10 (22.7) |
Enthesitis | 24 (72) | 1 (5.5) | NA | NA | NA | 18 (18.8) | NA |
Uveitis | 12 (37.5) | NA | 16 (22.5) | NA | 5 (10.4) | 7 (7.3) | NA |
Followup, mos | 480 | 65 ± 58 | NA | NA | 120 | NA | NA |
↵** Questionnaire-based survey. IBD: inflammatory bowel disease; SpA: spondyloarthritis; UC: ulcerative colitis; CD: Crohn disease; NA: not available.